{"entity":{"id":"hospital-universitario-salamanca","kind":"institution","name":"University Hospital of Salamanca / IBSAL","aka":["Hospital Universitario de Salamanca","Complejo Asistencial Universitario de Salamanca","Instituto de Investigación Biomédica de Salamanca"],"tldr":"Spanish university hospital whose haematology department, home of María-Victoria Mateos and the Spanish Myeloma Group, led the trials that defined treatment of smouldering and newly diagnosed myeloma.","summary":"The University Hospital of Salamanca and its research institute IBSAL form one of Europe's leading myeloma centres. Its haematology department, long associated with Jesús San Miguel and now with María-Victoria Mateos, coordinates the Spanish Myeloma Group (GEM/PETHEMA) and led the trials of lenalidomide in high-risk smouldering myeloma, the ALCYONE trial of daratumumab in transplant-ineligible patients and the flow cytometry methods for measuring minimal residual disease.","asOf":"2026-09-18","links":[],"tags":[],"related":[],"cancers":["multiple-myeloma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":["maria-victoria-mateos"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Salamanca","country":"ES","lat":40.959,"lng":-5.672,"institutionType":"hospital","university":"Universidad de Salamanca","programs":["Multiple myeloma (GEM/PETHEMA)","Minimal residual disease","Haematology"]},"route":"/institutions/hospital-universitario-salamanca/","neighbours":{"cancer":[{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"}],"person":[{"id":"maria-victoria-mateos","kind":"person","name":"María-Victoria Mateos","route":"/people/maria-victoria-mateos/"}]}}